For clinical trial recruitment companies to improve their numbers, they must take advantage of all forms of digital media. In the same vein, fishbat explains how social media can help increase patient recruitment and retention rates. To ensure utmost effectiveness for...
Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas of fibrosis, lysosomal storage disorders and oncology, today announced the positive recommendation of the fourth and...
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer’s disease. Preclinical research found that the drug — called...
Mark Terry for Biospace writes: Last week was a busy week for clinical trial results. Here’s a look at some of the top stories and reporting. Novartis reported results from two clinical trials evaluating improvements in heart structure and function, as well as...
– Study will evaluate the potential of DSP107 and atezolizumab in NSCLC patients who are refractory to PD1/PD-L1 inhibitors – Patient enrolment expected to commence in H1/2020 KAHR Medical, a biopharmaceutical company developing a novel drug platform...
Evidence of Biological Activity in the Lung with Minimal Systemic Exposure Generally Well-Tolerated as a Single Dose in Healthy Volunteers and as a Once-daily Dose for Seven Days in Asthmatics DUBLIN, Sept. 9, 2019 /PRNewswire/ — Theravance Biopharma, Inc....
Email
Text